Bullfrog AI Holdings, Inc.

BFRG ·Healthcare, Drug Manufacturers - General, United States
Valuation › AI Valuation

AI Valuation

AI-generated fair value estimate for this company.

AI Fair Value $0.40
Market Price $0.61
Overvalued By 52.5%

Method: Net asset value: net cash ($5.08M cash less $0.13M debt = $4.95M) plus a platform-revenue multiple (8x TTM platform/licensing revenue of $0.30M = $2.4M), summed and divided by 18.54M shares outstanding

Reasoning: Bullfrog AI is a pre-profitability AI drug-discovery platform burning about $6M of cash a year with an unproven, early-stage glioblastoma pipeline (BF-222/BF-223), so a standard DCF is not yet meaningful; a net-cash-plus-modest-revenue-multiple approach gives a defensible fundamental floor rather than speculating on trial outcomes